Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Firazyr in ACE inhibitor-associated angioedema
NCT01574248Phase 4Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2011
- Primary completion
- Sep 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of icatibant in angiotensin-converting enzyme inhibitor-induced angioedema (ACEI-IA), sponsored by Vanderbilt University Medical Center. Started Aug 2011; status: terminated.
02
Drugs
icatibant
03
Conditions
angiotensin-converting enzyme inhibitor-induced angioedema (ACEI-IA)
Beyond the preview
Go deeper on NCT01574248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01574248.